Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Accumulated Depreciation : $-0.10 Mil (As of Jan. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Cotinga Pharmaceuticals Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Cotinga Pharmaceuticals's quarterly accumulated depreciation stayed the same from Jul. 2019 ($-0.10 Mil) to Oct. 2019 ($-0.10 Mil) but then increased from Oct. 2019 ($-0.10 Mil) to Jan. 2020 ($-0.10 Mil).

Cotinga Pharmaceuticals's annual accumulated depreciation declined from Apr. 2017 ($-0.12 Mil) to Apr. 2018 ($-0.11 Mil) but then stayed the same from Apr. 2018 ($-0.11 Mil) to Apr. 2019 ($-0.09 Mil).

Cotinga Pharmaceuticals Accumulated Depreciation Historical Data

The historical data trend for Cotinga Pharmaceuticals's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cotinga Pharmaceuticals Accumulated Depreciation Chart

Cotinga Pharmaceuticals Annual Data

Trend

Apr10

Apr11

Apr12

Apr13

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Accumulated Depreciation

Get a 7-Day Free Trial

-0.09

-0.10

-0.12

-0.11

-0.09

Cotinga Pharmaceuticals Quarterly Data
	Apr15	Jul15	Oct15	Jan16	Apr16	Jul16	Oct16	Jan17	Apr17	Jul17	Oct17	Jan18	Apr18	Jul18	Oct18	Jan19	Apr19	Jul19	Oct19	Jan20
Accumulated Depreciation	Get a 7-Day Free Trial															-0.09	-0.09	-0.10	-0.10	-0.10

Cotinga Pharmaceuticals Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Cotinga Pharmaceuticals Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Cotinga Pharmaceuticals's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cotinga Pharmaceuticals Inc (OTCPK:COTQF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C1P1

Website

http://www.cotingapharma.com

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.

Cotinga Pharmaceuticals (Cotinga Pharmaceuticals) Headlines

From GuruFocus

Cotinga Pharmaceuticals Reports Fiscal 2018 Third Quarter Financial and Operating Results

By GlobeNewswire GlobeNewswire • 04-03-2018

Cotinga Pharmacueticals Announces Closing of Unit Offering

By GlobeNewswire GlobeNewswire • 05-22-2019